Roche
Executive Summary
Philip Del Vecchio, MD, to director drug regulatory affairs; Edward Betof, PhD, to director of project management.
You may also be interested in...
COVID-19: FDA Schedules 4 More Virtual Town Halls Through February
The US agency has announced another month of webinars aimed at labs and manufacturers that are (or have) developed diagnostic tests for the novel coronavirus.
GSK Ends Tough Week With Ulcerative Colitis Therapy Termination
If bad luck comes in threes, GSK will be delighted to see the end of this week with dostarlimab approval delayed, bintrafusp failing in lung cancer and a Phase II of an ulcerative colitis drug discontinued.
Global Pharma Industry Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: